On March 6, 2016, Dr. Jorge Castillo spoke to the Philadelphia IWMF Support Group on Genomic-based Advances in WM. Dr. Castillo, of the Dana-Farber Cancer Institute, is one of the world’s leading clinicians for Waldenstrom’s macroglobulinemia, and provides a valuable perspective, especially since:


  • There are approximately 1,500 WM patients diagnosed each year in the United States.
  • Dr. Castillo sees approximately 750 WM patients each year!
  • Most community oncologists see 0, 1, 2, or 3 WM patients in their career; Dr. Castillo probably sees more WM patients in a morning than most oncologists see in a lifetime.

The video can be viewed on the IWMF website at http://www.iwmf.com/publications/other-videos-about-wm#Castillo. Please note that this video is almost 2 hours in length.

The IWMF supports everyone affected by Waldenstrom's macroglobulinemia while advancing the search for a cure. Please visit http://www.iwmf.com for more information.